Your browser is no longer supported. Please, upgrade your browser.
Settings
ZYXI [NASD]
Zynex, Inc.
Index- P/E84.38 EPS (ttm)0.15 Insider Own40.00% Shs Outstand34.81M Perf Week2.07%
Market Cap437.48M Forward P/E17.35 EPS next Y0.71 Insider Trans-1.40% Shs Float19.61M Perf Month-0.16%
Income5.20M PEG- EPS next Q0.11 Inst Own31.70% Short Float18.65% Perf Quarter-27.87%
Sales100.80M P/S4.34 EPS this Y-7.10% Inst Trans-0.15% Short Ratio12.55 Perf Half Y-24.69%
Book/sh1.65 P/B7.47 EPS next Y101.70% ROA7.20% Target Price- Perf Year-13.48%
Cash/sh0.91 P/C13.54 EPS next 5Y- ROE9.30% 52W Range10.66 - 22.89 Perf YTD-8.47%
Dividend- P/FCF- EPS past 5Y36.80% ROI15.90% 52W High-46.18% Beta0.88
Dividend %- Quick Ratio5.80 Sales past 5Y47.10% Gross Margin77.30% 52W Low15.57% ATR0.46
Employees768 Current Ratio6.90 Sales Q/Q60.60% Oper. Margin6.20% RSI (14)54.38 Volatility3.12% 3.76%
OptionableYes Debt/Eq0.01 EPS Q/Q-9.90% Profit Margin5.20% Rel Volume0.34 Prev Close12.33
ShortableYes LT Debt/Eq0.01 EarningsJul 29 AMC Payout0.00% Avg Volume291.50K Price12.32
Recom2.00 SMA205.75% SMA50-1.62% SMA200-18.40% Volume99,307 Change-0.08%
Jul-16-21Upgrade B. Riley Securities Neutral → Buy $19.50
Jul-16-21Upgrade B. Riley Securities Neutral → Buy $19 → $19.50
Mar-09-21Upgrade Northland Capital Market Perform → Outperform $22.50
Feb-26-21Downgrade B. Riley Securities Buy → Neutral $19
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $28 → $20
Jan-28-21Downgrade Northland Capital Outperform → Market Perform $22.50
Sep-14-20Upgrade H.C. Wainwright Neutral → Buy $25
Sep-09-20Upgrade Northland Capital Market Perform → Outperform $22.50
Jul-29-20Upgrade B. Riley FBR Neutral → Buy $28
Jul-20-20Initiated Piper Sandler Overweight $30
Jul-13-20Downgrade B. Riley FBR Buy → Neutral
Jul-10-20Reiterated H.C. Wainwright Neutral $20 → $30
Jun-16-20Downgrade Northland Capital Outperform → Market Perform
May-19-20Downgrade H.C. Wainwright Buy → Neutral $20
Apr-01-20Initiated Northland Capital Outperform $15
Sep-23-19Initiated H.C. Wainwright Buy $12
Oct-20-21 09:10AM  
Oct-13-21 09:15AM  
Oct-08-21 09:15AM  
Jul-30-21 02:02AM  
Jul-29-21 06:25PM  
04:01PM  
Jul-21-21 09:15AM  
Jul-16-21 07:12AM  
Jul-15-21 09:15AM  
Jul-14-21 08:39AM  
Jul-13-21 09:15AM  
Jul-08-21 09:15AM  
Jun-30-21 10:08AM  
Apr-30-21 05:30AM  
Apr-29-21 06:15PM  
04:01PM  
02:15PM  
Apr-20-21 09:15AM  
Apr-19-21 09:15AM  
Apr-12-21 09:15AM  
Apr-09-21 09:15AM  
Apr-08-21 10:53AM  
Mar-30-21 09:15AM  
Mar-09-21 02:45AM  
Mar-08-21 09:15AM  
Feb-26-21 12:12PM  
09:30AM  
Feb-25-21 05:35PM  
04:01PM  
02:15PM  
Feb-18-21 09:15AM  
Feb-04-21 06:49AM  
Feb-03-21 12:47PM  
Jan-28-21 04:30PM  
Jan-14-21 09:15AM  
Jan-12-21 09:00AM  
Jan-06-21 09:15AM  
07:49AM  
Dec-31-20 04:11AM  
Dec-30-20 05:00AM  
Dec-10-20 09:40PM  
Dec-01-20 05:34AM  
Nov-19-20 09:15AM  
Nov-17-20 09:15AM  
Oct-29-20 03:07PM  
Oct-27-20 08:31PM  
05:20PM  
04:01PM  
Oct-23-20 09:15AM  
Oct-20-20 09:15AM  
Oct-13-20 02:38AM  
Oct-12-20 11:35AM  
09:15AM  
Oct-06-20 09:15AM  
Sep-23-20 02:42PM  
Sep-14-20 10:16AM  
Sep-10-20 09:00AM  
Sep-04-20 12:01PM  
Sep-03-20 09:00AM  
Aug-26-20 12:27PM  
Aug-16-20 06:22AM  
Aug-05-20 08:20AM  
Jul-28-20 11:31PM  
04:26PM  
Jul-27-20 11:10AM  
Jul-24-20 09:37PM  
Jul-23-20 09:21AM  
Jul-16-20 03:14PM  
Jul-15-20 11:37AM  
Jul-14-20 11:43PM  
04:10PM  
Jul-10-20 12:46PM  
Jul-09-20 09:15AM  
Jun-15-20 02:46PM  
Jun-14-20 08:08PM  
Jun-12-20 09:59AM  
Jun-10-20 05:51PM  
Jun-09-20 11:29AM  
May-21-20 10:59AM  
May-18-20 09:11AM  
May-14-20 03:45PM  
May-13-20 11:29AM  
May-12-20 04:20PM  
May-05-20 10:55AM  
May-04-20 08:11AM  
Apr-29-20 02:01AM  
Apr-28-20 04:02PM  
12:53PM  
Apr-21-20 09:20AM  
Apr-17-20 11:41AM  
Apr-13-20 12:14PM  
Apr-07-20 09:24AM  
Apr-02-20 08:27AM  
Mar-30-20 09:15AM  
Mar-18-20 08:59PM  
Mar-02-20 01:01PM  
Feb-28-20 07:28AM  
06:24AM  
Feb-27-20 04:02PM  
Feb-25-20 11:22AM  
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandgaard ThomasPresident, CEO and ChairmanAug 06Sale15.17177,3202,689,82013,617,420Aug 10 06:39 PM
MOORHEAD DANIEL JChief Financial OfficerJun 14Sale16.157,000113,05013,483Jun 14 05:51 PM
MOORHEAD DANIEL JChief Financial OfficerJun 11Sale16.2915,000244,35020,483Jun 14 05:51 PM
MOORHEAD DANIEL JChief Financial OfficerJun 10Sale16.163,00048,48035,483Jun 14 05:51 PM